Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.
about
Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapyOverview of current immunotherapeutic strategies for gliomaVirotherapy: cancer gene therapy at last?Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver diseaseCombining cytotoxic and immune-mediated gene therapy to treat brain tumorsSyntheses of 1-[(2-hydroxyethoxy)methyl]- and 1-[(1,3-dihydroxy-2-propoxy)methyl]- derivatives of 5-substituted-2,4-difluorobenzene: unnatural acyclo thymidine mimics for evaluation as anticancer and antiviral agents.Gene therapy for diseases of the nervous system.Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer.Genetic regulatory elements introduced into neural stem and progenitor cell populations.Genetically engineered HSV in the treatment of glioma: a review.In situ use of suicide genes for therapy of brain tumours.Chemotherapy for high-grade gliomas.Progress with retroviral gene vectors.Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer modelGene therapy for infectious diseasesPlant thymidine kinase 1: a novel efficient suicide gene for malignant glioma therapyGene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives.Myoblast transfer of human erythropoietin gene in a mouse model of renal failureCombination gene therapy for liver metastasis of colon carcinoma in vivoAdenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma.Clinical development of experimental therapies for malignant glioma.Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection.In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.Gene therapy trials for the treatment of high-grade gliomas.Gene-directed enzyme prodrug therapy: a review of enzyme/prodrug combinations.Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas.Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.Tourette's syndrome in the year 2000.Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.Adenoviral virotherapy for malignant brain tumorsThe application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumorsThe current state of head and neck cancer gene therapy.Gene therapy for malignant brain tumors.Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.Controlling the Evolution of ResistanceGene therapy in India: a focus.Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase.C-5 hydroxyethyl and hydroxypropyl acyclonucleosides as substrates for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK): syntheses and biological evaluation.Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK.
P2860
Q24679781-C3B3BBE0-43E1-4AA5-8A98-4BFA177D9EB4Q26776345-D72B4999-FC09-49C9-81FB-BE4E86D6A213Q28066228-B8F53010-1397-468C-BB9F-6CB9682BFD9CQ28472958-7779EC41-D3D6-41DA-A001-F42F63C62D56Q31013320-C0FDBB86-2AE8-4176-B563-EA6EA5F157E5Q31618649-802DD2FB-9A6C-4B38-B3D6-91E2CDAD4BFAQ33582065-2BE291CA-382D-47C7-A20D-9871DE993513Q33649687-CD4ABD57-4063-49AE-88FA-DB31CC0F95C6Q33693779-D646A030-12DA-42A6-A7D6-2D9A7DA9522FQ33827571-4B611101-A3A3-43CF-9711-3CAE3FC07107Q33841658-218B83DE-22E6-423E-8D4A-49B6D91E7AB5Q33898570-C120A976-7E4C-4443-AC40-BD0A331A64A2Q33920752-8C0A8D73-3D8A-42B6-80F9-2F77963AD445Q33989165-D45FAB7D-85C0-41F6-AC4D-02D9FF21B2DEQ33992464-9DEF87B3-15B2-426A-B857-19BEE46852BFQ34132910-1A1291EA-E315-4143-8606-936C77DEEBB5Q34176439-B18D71A3-067E-48EB-A755-B7AD6FD3CBC6Q34210746-0BCE2B8F-DCB7-49E3-B785-2326FA79C688Q34480736-B28FD345-7550-4DCC-9EEA-3E2F221FBE9FQ34506962-AAF6A680-D149-425C-A19A-B2719CE579DFQ34782295-42396672-F9C2-4670-B351-F2F14855D1ECQ35152561-F82B8F57-2063-4E44-AA76-A3D6C6DD4857Q35687015-54DDA0F9-1C9C-42E7-842E-17BC13DD7ECCQ35871957-B97A79BA-C415-4E20-9388-B1D5102514AFQ35880459-BC0C875B-EA1E-4438-B84B-C4E9861131C2Q36179778-B0ABB689-11F3-45FB-8140-FBD66678593EQ36367428-BDF00FEE-7934-4091-A4B1-711C3FBA664BQ36668246-44092A1D-8511-4898-B854-E0CEDA9C0A67Q36846712-38107691-6883-4241-9740-7B47665F92DEQ37076376-1AF11507-6264-48FD-8D99-A20ED71234CFQ37223846-CC2A6D70-2A9D-4BFB-BA60-0B17C1B436ADQ37247954-CAB78FEC-D8B9-462A-BFB4-25079B5B78FDQ37595513-3957E0E2-886C-46A7-B92E-3AD202BDF095Q37610257-632D965E-DE17-4EBF-9935-AC56EA1E60EBQ37660477-0C96FA94-1EBC-4744-8B3C-19E4886A47ABQ37868426-AEDDCB82-8E6B-4133-8535-A0CC085BF27BQ38213212-16FA551F-306E-4BCE-A451-DA20F7256EFBQ38322056-4BA3E2CD-8CE1-41CB-AAA8-5A8B2294EF3FQ39156170-7BF34618-3A7A-4F98-BA6C-26E3EAEE8C3CQ39582825-9541FE64-D605-48C7-9B88-E8E43EE4B415
P2860
Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Gene therapy for the treatment ...... e and intravenous ganciclovir.
@en
type
label
Gene therapy for the treatment ...... e and intravenous ganciclovir.
@en
prefLabel
Gene therapy for the treatment ...... e and intravenous ganciclovir.
@en
P2093
P356
P1433
P1476
Gene therapy for the treatment ...... e and intravenous ganciclovir.
@en
P2093
P356
10.1089/HUM.1993.4.1-39
P577
1993-02-01T00:00:00Z